CO5170470A1 - Relajantes neuromusculares de aralquilo y aralquenilo mono-aciloxi sustituidos - Google Patents
Relajantes neuromusculares de aralquilo y aralquenilo mono-aciloxi sustituidosInfo
- Publication number
- CO5170470A1 CO5170470A1 CO00005913A CO00005913A CO5170470A1 CO 5170470 A1 CO5170470 A1 CO 5170470A1 CO 00005913 A CO00005913 A CO 00005913A CO 00005913 A CO00005913 A CO 00005913A CO 5170470 A1 CO5170470 A1 CO 5170470A1
- Authority
- CO
- Colombia
- Prior art keywords
- substituted
- mono
- aralquenilo
- aciloxi
- aralquilo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Steroid Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Un compuesto CARACTERIZADO porque tiene la fórmula general a<EMI FILE="00005913_1" ID="1" IMF=JPEG >o la Fórmula general b<EMI FILE="00005913_2" ID="2" IMF=JPEG >donde R1 y R1´ son aralquilo o aralquenilo mono-aciloxi sustituido; R2 y R2´ son alquilo, o alquinilo; A es alcanodicarbonilo, alquenodicarbonilo, alquinodicarbonilo, cicloalcanodicarbonilo, cicloalquenodicarbonilo, bicicloalcanodicarbonilo, bicicloalquenodicarbonilo, poIicicloalcanodicarbonilo, poIicicloalquenodicarbonilo o dicarbonilo aromático, normales o sustituidos; n es 0, 1 ó 2; m es 0, 1 ó 2; p es 0, 1 ó 2; R3 y R3´ son H, CH3 ó alquilo inferior; R4 y R4´ son H, CH3 ó alquilo inferior; ó R3 y R4 juntos forman -CH=CH-, -(CH2)h-Y-(CH2)k-,<EMI FILE="00005913_3" ID="3" IMF=JPEG >
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11839299P | 1999-02-01 | 1999-02-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5170470A1 true CO5170470A1 (es) | 2002-06-27 |
Family
ID=22378296
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO00005913A CO5170470A1 (es) | 1999-02-01 | 2000-02-01 | Relajantes neuromusculares de aralquilo y aralquenilo mono-aciloxi sustituidos |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1150673A4 (es) |
| JP (1) | JP2002535366A (es) |
| KR (1) | KR20010108125A (es) |
| CN (1) | CN1338934A (es) |
| AR (1) | AR022472A1 (es) |
| AU (1) | AU2634900A (es) |
| BR (1) | BR0007863A (es) |
| CA (1) | CA2360790A1 (es) |
| CO (1) | CO5170470A1 (es) |
| CZ (1) | CZ20012780A3 (es) |
| HK (1) | HK1039455A1 (es) |
| HU (1) | HUP0200413A3 (es) |
| IL (1) | IL144249A0 (es) |
| MX (1) | MXPA01007783A (es) |
| NO (1) | NO20013741L (es) |
| NZ (1) | NZ513064A (es) |
| PE (1) | PE20001593A1 (es) |
| PL (1) | PL349099A1 (es) |
| TR (1) | TR200102196T2 (es) |
| WO (1) | WO2000044377A1 (es) |
| ZA (1) | ZA200105882B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0204087D0 (en) * | 2002-02-21 | 2002-04-10 | Legislator 1563 Ltd | Di-ester derivatives as short acting neuromuscular blockers |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2746964A (en) * | 1953-11-02 | 1956-05-22 | Lakeside Lab Inc | Dicarboxylic acid esters of nu-alkyl-3-hydroxypiperidine and salts thereof |
| AT292702B (de) * | 1968-12-29 | 1971-09-10 | Egyt Gyogyszervegyeszeti Gyar | Verfahren zur Herstellung von neuen N-Metyl-piperidin-Derivaten sowie der Säureadditionssalze und der Oniumderivate dieser Verbindungen |
| US5494898A (en) * | 1991-02-13 | 1996-02-27 | Ohmeda Pharmaceutical Products Division Inc. | Peptide skeletal muscle relaxants |
| US5990124A (en) * | 1997-10-24 | 1999-11-23 | Gyermek; Laszlo | Neuromuscular relaxants |
-
2000
- 2000-01-31 JP JP2000595680A patent/JP2002535366A/ja not_active Withdrawn
- 2000-01-31 MX MXPA01007783A patent/MXPA01007783A/es unknown
- 2000-01-31 TR TR2001/02196T patent/TR200102196T2/xx unknown
- 2000-01-31 NZ NZ513064A patent/NZ513064A/en unknown
- 2000-01-31 IL IL14424900A patent/IL144249A0/xx unknown
- 2000-01-31 PL PL00349099A patent/PL349099A1/xx not_active Application Discontinuation
- 2000-01-31 WO PCT/US2000/002228 patent/WO2000044377A1/en active Search and Examination
- 2000-01-31 CA CA002360790A patent/CA2360790A1/en not_active Abandoned
- 2000-01-31 EP EP00904621A patent/EP1150673A4/en not_active Withdrawn
- 2000-01-31 KR KR1020017009305A patent/KR20010108125A/ko not_active Application Discontinuation
- 2000-01-31 CZ CZ20012780A patent/CZ20012780A3/cs unknown
- 2000-01-31 CN CN00803305A patent/CN1338934A/zh active Pending
- 2000-01-31 BR BR0007863-8A patent/BR0007863A/pt not_active IP Right Cessation
- 2000-01-31 AU AU26349/00A patent/AU2634900A/en not_active Abandoned
- 2000-01-31 PE PE2000000069A patent/PE20001593A1/es not_active Application Discontinuation
- 2000-01-31 HU HU0200413A patent/HUP0200413A3/hu unknown
- 2000-02-01 CO CO00005913A patent/CO5170470A1/es not_active Application Discontinuation
- 2000-02-01 AR ARP000100432A patent/AR022472A1/es not_active Application Discontinuation
-
2001
- 2001-07-17 ZA ZA200105882A patent/ZA200105882B/en unknown
- 2001-07-31 NO NO20013741A patent/NO20013741L/no not_active Application Discontinuation
-
2002
- 2002-02-08 HK HK02100995.3A patent/HK1039455A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002535366A (ja) | 2002-10-22 |
| NO20013741D0 (no) | 2001-07-31 |
| HUP0200413A3 (en) | 2002-11-28 |
| MXPA01007783A (es) | 2002-08-20 |
| ZA200105882B (en) | 2003-02-18 |
| HUP0200413A2 (en) | 2002-06-29 |
| EP1150673A4 (en) | 2002-04-24 |
| CN1338934A (zh) | 2002-03-06 |
| PE20001593A1 (es) | 2001-01-16 |
| BR0007863A (pt) | 2001-11-06 |
| EP1150673A1 (en) | 2001-11-07 |
| AR022472A1 (es) | 2002-09-04 |
| TR200102196T2 (tr) | 2002-01-21 |
| HK1039455A1 (zh) | 2002-04-26 |
| PL349099A1 (en) | 2002-07-01 |
| IL144249A0 (en) | 2002-05-23 |
| NZ513064A (en) | 2003-08-29 |
| AU2634900A (en) | 2000-08-18 |
| CZ20012780A3 (cs) | 2002-01-16 |
| NO20013741L (no) | 2001-09-19 |
| CA2360790A1 (en) | 2000-08-03 |
| KR20010108125A (ko) | 2001-12-07 |
| WO2000044377A1 (en) | 2000-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL350077I1 (nl) | Cyprosulfamide | |
| PT984778E (pt) | Ligandos do neuropeptido y | |
| CO5140093A1 (es) | Epotilonas c 21 modificadas | |
| ID28026A (id) | Senyawa-senyawa 1,2,3,4-tetrahidrokuinolina-tersubstitusi-4-karboksiamino-2 sebagai penghambat-penghambat cetp | |
| ATE245636T1 (de) | Benzofurylpiperazine: 5-ht2c serotoninrezeptor agonisten | |
| NO982872L (no) | Forbindelser med veksthormonfrigjörende egenskaper | |
| DE69817802D1 (de) | Substituierte phenylderivate, ihre herstellung und verwendung | |
| AR248397A1 (es) | N-(fenil)pirazol-4-carboamidas novedosas utiles como fungicidas, composiciones fungicidas que las contienen y metodo para controlar enfermedades de plantas por hongos mediante dichos compuestos. | |
| ATE210163T1 (de) | Triazinpolymere und deren verwendung in elektrolumineszierenden anordnungen | |
| DE69718194T2 (de) | Amidinophenyl-pyrrolidine, -pyrroline und -isoxazolidine und ihre derivate | |
| ATE407155T1 (de) | Pyridin-imin polymerisationskatalysator | |
| AU3110999A (en) | Disubstituted pyrazolines and triazolines as factor xa inhibitors | |
| EP1029860A4 (en) | BENZOFURAN DERIVATIVES | |
| CO5261566A1 (es) | Compuestos antipicornavirales y composiciones, sus usos farmaceuticos y materiales para su sintesis | |
| TR199900363T2 (xx) | NK1 ve NK2 antagonistleri olarak asilaminoalkenilen-amid t�revleri. | |
| ES2172029T3 (es) | 3-amino-1-cianofenil-uracilos. | |
| BG105847A (en) | Calcilytic compounds | |
| CO5400148A1 (es) | Derivados de pirazoles que son antagonistas de cck-1 | |
| BG104232A (en) | Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazozocyn-10-ols, method for their preparation and application as medicamentous forms | |
| BG103789A (en) | Fungicidal compositions | |
| CO5170470A1 (es) | Relajantes neuromusculares de aralquilo y aralquenilo mono-aciloxi sustituidos | |
| ATE326512T1 (de) | Mischungen von beta-hydroxyalkylamiden und ihre verwendung als vernetzungsmittel bei der herstellung von pulverlacken | |
| MX9603199A (es) | Antagonistas de receptores a endotelina. | |
| DE60031269D1 (de) | Halbsynthese von paclitaxel mit hilfe von dialkyldichlorsilanen | |
| SE9701011D0 (sv) | 4-acylamidopiperidinföreningar i stabilisatorkombinationer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Application refused |